Launch Directory/Tech & SaaS/Magdalena Tyrpien
Magdalena Tyrpien

Magdalena Tyrpien · Launch Video Breakdown: Hook, Pacing & Motion Design

I’m proud to announce the launch of @NionyxBio with our $4M seed financing, led by @2048vc with participation from Empire State Development (NY Ventures), White Mug Healthcare, AIN Ventures,and Pathway Bioventures. Together with our Co-Founder & CTO Leszek Lisowski, PhD, MBA https://t.co/rS3GZeEOb4

Tech & SaaSLaunchSeptember 29, 2025@Mtyrpien
0:00 · The Hook · Company Introduction & Seed Funding Announcement
0:00 / 0:00

Scene-by-scene timeline & spoken transcript

  1. The Hook

    Company Introduction & Seed Funding Announcement

    “Hi, I am Magdalena Tyrpien, Co-Founder and CEO of Nionyx Bio, and I am so excited today to announce our $4 million seed led by 2048 Ventures and an incredible group of partners that understand the need to find therapies for rare kidney diseases.”

    On screen
    NIONYX ENGINEERING THE FUTURE OF GENE THERAPY Magdalena Tyrpien, MBA Co-Founder, President & CEO NIONYX 2048 VENTURES New York Ventures WHITE MUG VENTURES PATHWAY BIOVENTURES
    Camera
    Static wide shot of the founder, then a slight zoom in as partner logos animate on screen.
    Motion
    Text reveal with a subtle fade-in and scale-up. Partner logos animate in from the right with a staggered slide and fade.
  2. Product Reveal

    AAV Kidney Atlas & Precision Platform

    “At Nionyx Bio we are building the first ever AAV Kidney Atlas, and what we're able to do is look at our platform and make sure that AAV goes into the right kidney cell type.”

    On screen
    Leszek Lisowski, PhD, MBA Co-Founder, Chief Technical Officer NIONYX
    Camera
    Medium shot of the CTO in a lab setting, panning slightly to follow his actions.
    Motion
    Text overlay for CTO's title and company logo. Subtle camera pan to follow the action in the lab.
  3. Feature Teaser

    Gene Therapy Philosophy: Safe, Efficacious, Low Dose

    “By doing so, we're able to bring safer, more efficacious treatments at much lower doses. Breakthroughs happen when three things come together. Great science, a clear understanding of patient need and the business acumen to connect the pieces. That's how we're engineering the future of gene therapy.”

    On screen
    SAFE EFFECATIOUS LOW DOSE
    Camera
    Static wide shot of the founder, then a slight zoom in for emphasis.
    Motion
    Keywords (SAFE, EFFECATIOUS, LOW DOSE) animate in with a quick, impactful scale and fade from the left, center, and right respectively. Subtle camera zoom for emphasis on the founder's gestures.
  4. Call to Action

    The Trifecta of Gene Therapy & Future Vision

    “It's the trifecta, it's capsid, it's cassette, it's delivery, it's all purpose built for precision, but most importantly for safety, and we're starting with the kidney.”

    On screen
    CAPSID CASSETTE
    Camera
    Static wide shot of the founder, then a slight zoom in.
    Motion
    Keywords (CAPSID, CASSETTE) animate in with a quick, impactful scale and fade. The scene ends with a fade to black, emphasizing the final statement.

Related Tech & SaaS Product Launches

Explore all Tech & SaaS launches →
bolt.new
Hook 9.256.3M
bolt.newDeveloper Tools

Bolt v2 pairs Claude Code and Codex agents with built-in hosting, database and storage so apps ship without setup.

@boltdotnew
SpaceX
Hook 9.244.7M
SpaceXAI Agents

Making life multiplanetary

@SpaceX
Vaibhav Sisinty
Hook 9.224.5M

Did xAI just mass-murder the entire voice AI industry? Grok just launched two voice APIs. Speech-to-Text and Text-to-Speech. Built on the same stack powering Tesla cars and Starlink support. And pr…

@VaibhavSisinty